Idexx Laboratories IDXX Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's accrued liabilities, current?
- Idexx Laboratories (IDXX) reported accrued liabilities, current of $453.55M in Q1 2026.
- How has Idexx Laboratories's accrued liabilities, current changed year-over-year?
- Idexx Laboratories's accrued liabilities, current decreased by 7.6% year-over-year, from $490.69M to $453.55M.
- What is the long-term trend for Idexx Laboratories's accrued liabilities, current?
- Over 5 years (2020 to 2025), Idexx Laboratories's accrued liabilities, current has grown at a 5.0% compound annual growth rate (CAGR), from $415.65M to $530.15M.
- What does accrued liabilities, current mean?
- These are short-term obligations for expenses that have been incurred but not yet invoiced or paid, such as employee compensation or accrued taxes. They represent necessary operational costs that will require cash outflow in the near term.